What is Capsule Shell Market?
The capsule shell is an outer coating in which the drug medicaments are enclosed. The capsule shell act as a protective container for medicaments inside. These capsule shells are made up of gelatin as well as non-gelatin material. The capsule shell is made up of both soft gelatin and hard gelatin. The hard gelatin capsule shell is used for drug powders and pellets whereas, the soft gelatin shell is used for liquid medicaments. The majority of capsule shells are derived from hydrolysis of collagen from animal origin.
The market study is being classified by Type (Gelatin Capsule [Hard Gelatin Capsule, Soft Gelatin Capsule] and Non-Gelatin Capsule), by Application (Antibiotic Drugs, Vitamin and Dietary Supplements, Antacid Preparations, Cardiac Therapy Drug and Others) and major geographies with country level break-up.
ACG Worldwide (India), Bright Pharma Caps Inc. (United States), CapsCanada Corporation (Canada), Lonza Group Ltd. (Switzerland), Medi-Caps Ltd. (India), Mitsubishi Chemical Holdings Corporation (Japan), Roxlor LLC (United States), Snail Pharma Industry Co. Ltd. (China), Suheung Co., Ltd. (South Korea) and Sunil Healthcare Ltd. (India) are some of the key players profiled in the study.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Asian Players will contribute to the maximum growth of Global Capsule Shell market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Capsule Shell market by Type, Application and Region.
On the basis of geography, the market of Capsule Shell has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Rising Popularity of Capsule Dosage Form
- Increase in the Geriatric Population
Market Trend
- A Rising Trend in the Adoption of Capsule over Tablets and Liquids
Restraints
- Stringent Regulatory Approvals and Regulations
Opportunities
- Rising R&D Investments by Pharmaceutical Companies
Challenges
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Capsule Shell, Venture Capitalists and Private Equity Firms and End-Use Industry